Current Issue - Silder
Current Issue: February 2021
This month's highlight articles
Argon plasma coagulation for Barrett’s esophagus with low-grade dysplasia: a randomized trial with long-termfollow-up on the impact of power setting and proton pump inhibitor dose
Argon plasma coagulation (APC) and proton pump inhibitors (PPIs) for Barrett’s esophagus (BE) with low grade dysplasia were compared between high power APC/high PPI, high power APC/low PPI, and low power APC/high PPI groups. No differences in complete ablation rates were found between power settings and PPI doses, and response was durable in more than 90% of patients, with no neoplastic progression in the long term. However, patients on high power APC developed more chest pain and discomfort.
Endoscopic management of enteral tubes in adult patients – Part 2: Peri- and post-procedural management. European Society of Gastrointestinal Endoscopy (ESGE) Guideline
This is Part 2 of a two-part Guideline from the European Society of Gastrointestinal Endoscopy (ESGE) that addresses all major issues concerning endoscopic enteral tube management. Part 2 focuses on peri- and post-procedural considerations, including adverse events as well as modalities of treatment and prevention.
Overcoming the barriers to dissemination and implementation of quality measures for gastrointestinal endoscopy: European Society of Gastrointestinal Endoscopy (ESGE) and United European Gastroenterology (UEG) Position Statement
ESGE and UEG have developed performance measures to assess quality in all fields of endoscopy practice. In this Position Statement, they address the potential barriers to implementation and suggest solutions and points for action to overcome these barriers.